ACN Newswire

Tue May 25

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion

Written by ACN Newswire

HONG KONG, May 24, 2021 - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021.

Develo...

ACN Newswire

Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion

'Honeygate' deepens as new tests reveal 27% of brands are adulterated

Dogs really can chase away loneliness

View from The Hill: Scott Morrison eases refugee policy while talking tough

Three reasons why the gaps between Indigenous and non-Indigenous Australians aren't closing

Giving workers a voice in the boardroom is a compelling corporate governance reform

We Buy Houses Bethel Park – Get a Fair Cash Offer Today

Denied full participation, Catholic women mobilise for change

Street vendors' self-help strategies highlight cities' neglect of how the other half survive

Australians disagree on how important climate change is: poll

Native cherries are a bit mysterious, and possibly inside-out

It's hard to know when to come out from under the doona. It'll be soon, but not yet